Previous close | 0.6300 |
Open | 1.0200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 170.00 |
Expiry date | 2024-06-07 |
Day's range | 0.6000 - 1.1200 |
Contract range | N/A |
Volume | |
Open interest | 1.37k |
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.